Viewing Study NCT02131506

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-26 @ 11:00 AM
Ignite Modification Date: 2026-02-26 @ 6:28 AM
Study NCT ID: NCT02131506
Status: TERMINATED
Last Update Posted: 2016-02-02
First Post: 2014-05-05
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study of Lapatinib in Combination With Caelyx in Patients With Advanced HER2 Positive Pretreated Breast Cancer
Sponsor: Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HER-2 Positive Breast Cancer View
None Malignant Neoplasm of Breast View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Advanced HER2 positive Breast Cancer View
None pretreated breast cancer View
None advanced disease View